ArticleJournal of clinical medicine2026
Severe Hypercalcemia and Acute Kidney Injury in a Patient with Probable IgG4-Related Disease and Cholestatic Liver Injury: A Case Report.
Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
We report a 54-year-old man with a history of urticaria, hyperlipidemia, and hypertension who was receiving regular bisoprolol, rosuvastatin, and verapamil. He initially developed severe hypercalcemia (18.56 mg/dL) and acute kidney injury (serum creatinine, 5.14 mg/dL) while in China. Following intravenous hydration and calcitonin, serum calcium normalized and renal function substantially improved. During hospitalization, he subsequently developed marked eosinophilia, severe thrombocytopenia, cholestatic liver injury, lymphadenopathy, and markedly elevated serum IgG4 (851 mg/dL). Extensive evaluation did not identify evidence of malignancy or infection. The overall findings raised clinical suspicion of IgG4-related disease (IgG4-RD) with possible hepatobiliary involvement and suspected immune-mediated thrombocytopenia. Ursodeoxycholic acid and fenofibrate were initiated when primary biliary cholangitis remained under consideration, followed by systemic corticosteroid therapy with dexamethasone. The patient's liver abnormalities, thrombocytopenia, eosinophilia, and systemic manifestations subsequently improved. However, definitive tissue confirmation of IgG4-RD was not obtained, and characteristic cholangiographic evidence of IgG4-related sclerosing cholangitis was unavailable because MRCP or ERCP was not performed. During six months of outpatient follow-up, renal function remained stable and no clinical or biochemical relapse was observed. This case highlights severe hypercalcemia and acute kidney injury as unusual presenting features in a patient with clinical suspicion of IgG4-RD and emphasizes the importance of cautious diagnostic interpretation when histopathological and cholangiographic confirmation is unavailable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.